Biomay AG
Vienna, Austria · biomay.com
GMP
Biomay AG is a biopharmaceutical CDMO in Vienna, Austria. It manufactures GMP-grade plasmid DNA, mRNA, recombinant proteins, and related drug products for clinical phases I–III and market supply. The company operates two GMP manufacturing sites in Vienna.
They take quote requests through a form on their website with project details. Their quote form
What they offer
Vector development
Develops vectors for plasmids, proteins, and mRNA.
GMP cell banking
Creates Master Cell Banks and Working Cell Banks.
Process development and feasibility studies
Carries out process development and feasibility work for client projects.
Analytical development / quality control methods
Develops analytical methods and quality control methods for project support.
GMP manufacturing of bulk drug substance
Manufactures bulk drug substance for clinical phases I–III and market supply.
GMP aseptic filling of drug product
Performs aseptic filling of drug product for clinical phases I–III.
Quality control and Qualified Person release
Provides quality control and QP release services.
Analytical method and process validation (PPQ)
Supports analytical method validation and process validation activities.
Regulatory support
Provides regulatory support for client programs.
ICH stability testing & long-term storage
Conducts ICH stability testing and long-term storage.
Aseptic filling
Offers cGMP fill & finish services for DNA, proteins, and RNA.
Personalized manufacturing
Manufactures patient-specific DNA and mRNA cancer vaccines within a few weeks.
What they work on
- Modalities
- mRNA, Viral vector, Gene editing, Recombinant protein, Vaccine, Plasmid DNA, LNP / formulation
- Species and models
- E. coli
- Assays and studies
- analytical development, quality control, qualified person release, analytical method validation, process validation, ICH stability testing, in-house rapid sterility testing, assay development
- Instruments and platforms
- automated filling / stoppering line, high-pressure homogenizers, centrifuges, process chromatography equipment
- Scale and capacity
- two GMP manufacturing sites, 10 segregated GMP clean room suites, total floor space 6000 sqm / 60,000 sq ft, headquarter facility 4000 sqm total floor space, mRNA Competence Center 2000 sqm total floor space, bioreactor capacities: 30L, 50L, 150L, 750L, personalized bioreactor capacities: 4 x 3L, capacity up to 1500 2R glass vials per batch, up to 1500 sterile-filled vials per batch, up to 50 mg mRNA per patient, up to 300 mg DNA per patient
- Therapeutic areas
- cancer immunotherapy, gene editing, ATMPs
- Turnaround
- within a couple of weeks · from incoming of starting material to released mRNA-LNP in three weeks · from incoming of starting material to released plasmid DNA in two weeks · personalized DNA cancer vaccines in as little as two weeks · mRNA-based vaccines in approximately three weeks
- What to send
- In-silico sequence of individual patient mRNA provided by sponsor · DNA fragment synthesis as starting material (external) · In-silico sequence of individual patient DNA provided by sponsor
- Type
- CDMO
- Sites
- Vienna, Austria · Vienna 1220 (Aspern Seestadt), Austria · Vienna 1090, Austria
- Quality
- GMP (plasmid DNA, mRNA, recombinant proteins, aseptic filling, personalized batches) · cGMP (fill & finish services for DNA, proteins, and RNA) · ICH and EMA directives (2001/83/EC, 2001 · FDA inspected (company facilities) · FDA-grade (CRISPR/Cas9 nuclease)
- Serves
- North America
- Address
- Ada-Lovelace-Straße 2; 1220 Vienna, Austria
- Founded
- 1984
Public records
- Ownership
- BIOMAY AG · AT GLEIF
Similar labs. Artis, Crystal NAX, Rose BioSolutions, Miltenyi Bioindustry
Found in a contract services directory. Listing built from biomay.com. Work here? Claim this listing.